Private-equity firm General Atlantic has sold its majority stake in cancer-care specialist OneOncology through a deal that values the business at $2.1 billion.
Private-equity firm General Atlantic has sold its majority stake in cancer-care specialist OneOncology through a deal that values the business at $2.1 billion.
All the week’s industry events straight to your inbox.
By signing up you agree to our terms of use and privacy policy.
7 Bell Yard, London, England, WC2A 2JR
You will soon receive a Reset Password link
By signing up you agree to terms of use and privacy policy.
Continue with Facebook Continue with Google